{"transactions":[{"id":3829565,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-30T16:09:04.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":4334,"price":40.2743,"value":174548.8162,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 28, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,334 shares in multiple trades at prices ranging from $40.00 to $40.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1041054,"source":{"system":"sec-edgar","filing":"0001209191-18-048926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118048926/doc4.xml","form_type":"4"}},{"id":3831625,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-28T16:22:47.000Z","date":"2018-08-27","kind":"sale","acquired":false,"shares":13450,"price":40.0493,"value":538663.085,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,450 shares in multiple trades at prices ranging from $40.00 to $40.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1045388,"source":{"system":"sec-edgar","filing":"0001209191-18-048680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118048680/doc4.xml","form_type":"4"}},{"id":3831624,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-28T16:22:47.000Z","date":"2018-08-24","kind":"sale","acquired":false,"shares":12216,"price":40.0004,"value":488644.8864,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 12,216 shares in multiple trades at prices ranging from $40.00 to $40.05. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1058838,"source":{"system":"sec-edgar","filing":"0001209191-18-048680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118048680/doc4.xml","form_type":"4"}},{"id":3865321,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-07-18T17:14:52.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":27685,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,685 shares in multiple trades at prices ranging from $35.00 to $35.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1071054,"source":{"system":"sec-edgar","filing":"0001209191-18-043113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118043113/doc4.xml","form_type":"4"}},{"id":3865320,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-07-18T17:14:52.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":2315,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,315 shares in multiple trades at prices ranging from $36.00 to $36.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1098739,"source":{"system":"sec-edgar","filing":"0001209191-18-043113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118043113/doc4.xml","form_type":"4"}},{"id":3888846,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-19T16:12:50.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":30000,"price":31.0934,"value":932802.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 15, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $30.875 to $31.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1101054,"source":{"system":"sec-edgar","filing":"0001209191-18-038534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118038534/doc4.xml","form_type":"4"}},{"id":3892627,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-06-15T16:23:43.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":30000,"price":31.6423,"value":949269.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 14, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $31.40 to $31.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1131054,"source":{"system":"sec-edgar","filing":"0001209191-18-038048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118038048/doc4.xml","form_type":"4"}},{"id":3953658,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-30T17:03:55.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":14766,"price":26.33,"value":388788.78,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 14,766 shares in multiple trades at prices ranging from $26.00 to $26.75. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1161054,"source":{"system":"sec-edgar","filing":"0001209191-18-026882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118026882/doc4.xml","form_type":"4"}},{"id":3953657,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-30T17:03:55.000Z","date":"2018-04-26","kind":"sale","acquired":false,"shares":6200,"price":25.52,"value":158224.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,200 shares in multiple trades at prices ranging from $25.00 to $25.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1175820,"source":{"system":"sec-edgar","filing":"0001209191-18-026882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118026882/doc4.xml","form_type":"4"}},{"id":3957205,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-25T16:08:40.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":5600,"price":25.0571,"value":140319.76,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 5,600 shares in multiple trades at prices ranging from $25.00 to $25.25. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1182020,"source":{"system":"sec-edgar","filing":"0001209191-18-026066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118026066/doc4.xml","form_type":"4"}},{"id":3957204,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-25T16:08:40.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":30000,"price":25.0654,"value":751962.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 23, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $25.00 to $25.40. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1187620,"source":{"system":"sec-edgar","filing":"0001209191-18-026066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118026066/doc4.xml","form_type":"4"}},{"id":3958619,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-23T16:05:44.000Z","date":"2018-04-20","kind":"sale","acquired":false,"shares":19362,"price":25.0585,"value":485182.677,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 20, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 19,362 shares in multiple trades at prices ranging from $24.575 to $25.30. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1217620,"source":{"system":"sec-edgar","filing":"0001209191-18-025821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118025821/doc4.xml","form_type":"4"}},{"id":3958618,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-23T16:05:44.000Z","date":"2018-04-19","kind":"sale","acquired":false,"shares":16081,"price":25.06,"value":402989.86,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 19, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 16,081 shares in multiple trades at prices ranging from $25.00 to $25.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1236982,"source":{"system":"sec-edgar","filing":"0001209191-18-025821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118025821/doc4.xml","form_type":"4"}},{"id":3958617,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-23T16:05:44.000Z","date":"2018-04-19","kind":"sale","acquired":false,"shares":13919,"price":24.79,"value":345052.01,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 19, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,919 shares in multiple trades at prices ranging from $24.45 to $24.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1253063,"source":{"system":"sec-edgar","filing":"0001209191-18-025821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118025821/doc4.xml","form_type":"4"}},{"id":3960078,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-19T16:21:51.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":14072,"price":24.0961,"value":339080.3192,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 18, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 14,072 shares in multiple trades at prices ranging from $24.00 to $24.50. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1266982,"source":{"system":"sec-edgar","filing":"0001209191-18-025556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118025556/doc4.xml","form_type":"4"}},{"id":3960077,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2018-04-19T16:21:51.000Z","date":"2018-04-17","kind":"sale","acquired":false,"shares":30000,"price":23.4408,"value":703224.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 17, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $23.00 to $23.85. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1281054,"source":{"system":"sec-edgar","filing":"0001209191-18-025556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118025556/doc4.xml","form_type":"4"}},{"id":3968489,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-05T16:17:56.000Z","date":"2018-04-04","kind":"sale","acquired":false,"shares":30000,"price":19.8918,"value":596754.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $19.60 to $20.375. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1311054,"source":{"system":"sec-edgar","filing":"0001209191-18-024057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118024057/doc4.xml","form_type":"4"}},{"id":3969891,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-04T16:05:48.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":26300,"price":20.23,"value":532049.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On April 3, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 26,300 shares in multiple trades at prices ranging from $20.00 to $20.70. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1341054,"source":{"system":"sec-edgar","filing":"0001209191-18-023587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118023587/doc4.xml","form_type":"4"}},{"id":3969890,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-04T16:05:48.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":3700,"price":19.87,"value":73519.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 3, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 3,700 shares in multiple trades at prices ranging from $19.65 to $19.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1367354,"source":{"system":"sec-edgar","filing":"0001209191-18-023587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118023587/doc4.xml","form_type":"4"}},{"id":3969889,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-04T16:05:48.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":27489,"price":20.38,"value":560225.82,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,489 shares in multiple trades at prices ranging from $20.00 to $20.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1371054,"source":{"system":"sec-edgar","filing":"0001209191-18-023587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118023587/doc4.xml","form_type":"4"}},{"id":3969888,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-04T16:05:48.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":2511,"price":21.36,"value":53634.96,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,511 shares in multiple trades at prices ranging from $21.00 to $21.70. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1398543,"source":{"system":"sec-edgar","filing":"0001209191-18-023587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118023587/doc4.xml","form_type":"4"}},{"id":3976540,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-02T16:05:22.000Z","date":"2018-03-29","kind":"sale","acquired":false,"shares":4300,"price":22,"value":94600.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,300 shares in multiple trades at prices ranging from $21.95 to $22.10. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1401054,"source":{"system":"sec-edgar","filing":"0001209191-18-022352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118022352/doc4.xml","form_type":"4"}},{"id":3976539,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary shares","published_at":"2018-04-02T16:05:22.000Z","date":"2018-03-29","kind":"sale","acquired":false,"shares":25700,"price":21.61,"value":555377.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 25,700 shares in multiple trades at prices ranging from $20.95 to $21.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1405354,"source":{"system":"sec-edgar","filing":"0001209191-18-022352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919118022352/doc4.xml","form_type":"4"}},{"id":4163727,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-14T16:25:04.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":30000,"price":17.129,"value":513870.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $16.925 to $17.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1431054,"source":{"system":"sec-edgar","filing":"0001209191-17-060601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060601/doc4.xml","form_type":"4"}},{"id":4165731,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":3900,"price":18.04,"value":70356.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 3,900 shares in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1461054,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4165730,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":26100,"price":17.54,"value":457794.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 26,100 shares in multiple trades at prices ranging from $17.20 to $17.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1464954,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4165729,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":5388,"price":18.74,"value":100971.12,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 5,388 shares in multiple trades at prices ranging from $18.65 to $19.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1491054,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4165728,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":24612,"price":18.14,"value":446461.68,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 24,612 shares in multiple trades at prices ranging from $17.65 to $18.625. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1496442,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4165727,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":6266,"price":20.17,"value":126385.22,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,266 shares in multiple trades at prices ranging from $20.00 to $20.50. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1521054,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4165726,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-13T16:36:52.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":23734,"price":19.46,"value":461863.64,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 23,734 shares in multiple trades at prices ranging from $19.10 to $19.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1527320,"source":{"system":"sec-edgar","filing":"0001209191-17-060319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117060319/doc4.xml","form_type":"4"}},{"id":4168970,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-08T16:17:06.000Z","date":"2017-11-07","kind":"sale","acquired":false,"shares":2900,"price":21.14,"value":61306.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,900 shares in multiple trades at prices ranging from $20.975 to $21.40. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1551054,"source":{"system":"sec-edgar","filing":"0001209191-17-059744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117059744/doc4.xml","form_type":"4"}},{"id":4168969,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-08T16:17:06.000Z","date":"2017-11-07","kind":"sale","acquired":false,"shares":27100,"price":20.34,"value":551214.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,100 shares in multiple trades at prices ranging from $19.90 to $20.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1553954,"source":{"system":"sec-edgar","filing":"0001209191-17-059744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117059744/doc4.xml","form_type":"4"}},{"id":4168968,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-08T16:17:06.000Z","date":"2017-11-06","kind":"sale","acquired":false,"shares":30000,"price":21.708,"value":651240.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 6, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.45 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1581054,"source":{"system":"sec-edgar","filing":"0001209191-17-059744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117059744/doc4.xml","form_type":"4"}},{"id":4171462,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-06T16:22:50.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":30000,"price":21.656,"value":649680.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 3, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.35 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1611054,"source":{"system":"sec-edgar","filing":"0001209191-17-059405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117059405/doc4.xml","form_type":"4"}},{"id":4171461,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-06T16:22:50.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":30000,"price":21.784,"value":653520.0,"ownership":{"direct":false,"nature":"Bennett Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.50 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Professor Palti shares voting and investment power for the shares held by Bennett Limited."}],"balance_after":1641054,"source":{"system":"sec-edgar","filing":"0001209191-17-059405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117059405/doc4.xml","form_type":"4"}},{"id":4291118,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-06T17:17:35.000Z","date":"2017-06-05","kind":"sale","acquired":false,"shares":3825,"price":13.815,"value":52842.375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 3,825 shares in multiple trades at prices ranging from $13.70 to $13.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-038176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117038176/doc4.xml","form_type":"4"}},{"id":4293042,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-05T16:19:38.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":4000,"price":13.489,"value":53956.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $13.00 to $13.70. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3825,"source":{"system":"sec-edgar","filing":"0001209191-17-037699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117037699/doc4.xml","form_type":"4"}},{"id":4293041,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-05T16:19:38.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":4000,"price":13.046,"value":52184.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.60 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7825,"source":{"system":"sec-edgar","filing":"0001209191-17-037699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117037699/doc4.xml","form_type":"4"}},{"id":4298181,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-01T16:29:59.000Z","date":"2017-05-31","kind":"sale","acquired":false,"shares":4000,"price":12.473,"value":49892.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 31, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.15 to $12.65. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11825,"source":{"system":"sec-edgar","filing":"0001209191-17-036790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117036790/doc4.xml","form_type":"4"}},{"id":4298180,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-06-01T16:29:59.000Z","date":"2017-05-30","kind":"sale","acquired":false,"shares":4000,"price":12.501,"value":50004.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 30, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.375 to $12.70. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001209191-17-036790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117036790/doc4.xml","form_type":"4"}},{"id":4301327,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-30T17:08:59.000Z","date":"2017-05-26","kind":"sale","acquired":false,"shares":4000,"price":12.86,"value":51440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 26, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.65 to $13.10. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19825,"source":{"system":"sec-edgar","filing":"0001209191-17-036163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117036163/doc4.xml","form_type":"4"}},{"id":4301326,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-30T17:08:59.000Z","date":"2017-05-25","kind":"sale","acquired":false,"shares":4000,"price":12.891,"value":51564.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.55 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23825,"source":{"system":"sec-edgar","filing":"0001209191-17-036163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117036163/doc4.xml","form_type":"4"}},{"id":4304898,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-25T16:21:20.000Z","date":"2017-05-24","kind":"sale","acquired":false,"shares":1431,"price":13.428,"value":19215.468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 1,431 shares in multiple trades at prices ranging from $13.25 to $13.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27825,"source":{"system":"sec-edgar","filing":"0001209191-17-035351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117035351/doc4.xml","form_type":"4"}},{"id":4304897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-25T16:21:20.000Z","date":"2017-05-24","kind":"sale","acquired":false,"shares":2569,"price":13,"value":33397.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 2,569 shares in multiple trades at prices ranging from $12.25 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29256,"source":{"system":"sec-edgar","filing":"0001209191-17-035351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117035351/doc4.xml","form_type":"4"}},{"id":4306543,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-24T16:31:32.000Z","date":"2017-05-23","kind":"sale","acquired":false,"shares":4000,"price":11.8,"value":47200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 23, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.55 to $12.25. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31825,"source":{"system":"sec-edgar","filing":"0001209191-17-034948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117034948/doc4.xml","form_type":"4"}},{"id":4306542,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-24T16:31:32.000Z","date":"2017-05-22","kind":"sale","acquired":false,"shares":4000,"price":11.669,"value":46676.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 22, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.575 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":35825,"source":{"system":"sec-edgar","filing":"0001209191-17-034948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117034948/doc4.xml","form_type":"4"}},{"id":4310088,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-22T16:14:02.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":4000,"price":11.536,"value":46144.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.30 to $11.75. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39825,"source":{"system":"sec-edgar","filing":"0001209191-17-034278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117034278/doc4.xml","form_type":"4"}},{"id":4310087,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-22T16:14:02.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":4000,"price":11.239,"value":44956.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 18, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.05 to $11.50. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43825,"source":{"system":"sec-edgar","filing":"0001209191-17-034278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117034278/doc4.xml","form_type":"4"}},{"id":4313659,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-18T17:52:46.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":4000,"price":11.471,"value":45884.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 17, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.30 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47825,"source":{"system":"sec-edgar","filing":"0001209191-17-033702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117033702/doc4.xml","form_type":"4"}},{"id":4315970,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-17T16:14:46.000Z","date":"2017-05-16","kind":"sale","acquired":false,"shares":4000,"price":11.901,"value":47604.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 16, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.75 to $12.075. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51825,"source":{"system":"sec-edgar","filing":"0001209191-17-033045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117033045/doc4.xml","form_type":"4"}},{"id":4315969,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-17T16:14:46.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":4000,"price":12.189,"value":48756.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 15, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.85 to $12.35. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":55825,"source":{"system":"sec-edgar","filing":"0001209191-17-033045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117033045/doc4.xml","form_type":"4"}},{"id":4320947,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-15T16:45:31.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":4000,"price":11.693,"value":46772.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 12, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.55 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":59825,"source":{"system":"sec-edgar","filing":"0001209191-17-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117032358/doc4.xml","form_type":"4"}},{"id":4320946,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-15T16:45:31.000Z","date":"2017-05-11","kind":"sale","acquired":false,"shares":4000,"price":11.877,"value":47508.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.70 to $12.15. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":63825,"source":{"system":"sec-edgar","filing":"0001209191-17-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117032358/doc4.xml","form_type":"4"}},{"id":4324825,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-11T16:04:21.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":4000,"price":12.248,"value":48992.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.10 to $12.45. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67825,"source":{"system":"sec-edgar","filing":"0001209191-17-031517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117031517/doc4.xml","form_type":"4"}},{"id":4324824,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-11T16:04:21.000Z","date":"2017-05-09","kind":"sale","acquired":false,"shares":4000,"price":12.327,"value":49308.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.10 to $12.50. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":71825,"source":{"system":"sec-edgar","filing":"0001209191-17-031517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117031517/doc4.xml","form_type":"4"}},{"id":4328346,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-09T16:03:42.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":4000,"price":12.094,"value":48376.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.775 to $12.50. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":75825,"source":{"system":"sec-edgar","filing":"0001209191-17-030904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117030904/doc4.xml","form_type":"4"}},{"id":4328345,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-09T16:03:42.000Z","date":"2017-05-05","kind":"sale","acquired":false,"shares":4000,"price":11.55,"value":46200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.20 to $11.825. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":79825,"source":{"system":"sec-edgar","filing":"0001209191-17-030904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000120919117030904/doc4.xml","form_type":"4"}},{"id":4331766,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-05T16:05:47.000Z","date":"2017-05-04","kind":"sale","acquired":false,"shares":4000,"price":11.286,"value":45144.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 4, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.15 to $11.45. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":83825,"source":{"system":"sec-edgar","filing":"0000899243-17-011976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011976/doc4.xml","form_type":"4"}},{"id":4331765,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-05T16:05:47.000Z","date":"2017-05-03","kind":"sale","acquired":false,"shares":4000,"price":11.554,"value":46216.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 3, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.10 to $11.85. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":87825,"source":{"system":"sec-edgar","filing":"0000899243-17-011976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011976/doc4.xml","form_type":"4"}},{"id":4335365,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-03T16:05:36.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":4000,"price":11.836,"value":47344.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.725 to $11.950. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":91825,"source":{"system":"sec-edgar","filing":"0000899243-17-011613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011613/doc4.xml","form_type":"4"}},{"id":4335364,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-03T16:05:36.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":4000,"price":11.444,"value":45776.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.20 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":95825,"source":{"system":"sec-edgar","filing":"0000899243-17-011613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011613/doc4.xml","form_type":"4"}},{"id":4340444,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-01T16:07:22.000Z","date":"2017-04-28","kind":"sale","acquired":false,"shares":4000,"price":11.29,"value":45160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 28, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":99825,"source":{"system":"sec-edgar","filing":"0000899243-17-011267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011267/doc4.xml","form_type":"4"}},{"id":4340443,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-01T16:07:22.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":4000,"price":11.205,"value":44820.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 27, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.70 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103825,"source":{"system":"sec-edgar","filing":"0000899243-17-011267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011267/doc4.xml","form_type":"4"}},{"id":4343566,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-27T16:05:26.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":4000,"price":10.775,"value":43100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 26, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $10.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":107825,"source":{"system":"sec-edgar","filing":"0000899243-17-011007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011007/doc4.xml","form_type":"4"}},{"id":4343565,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-27T16:05:26.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":4000,"price":10.791,"value":43164.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $10.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":111825,"source":{"system":"sec-edgar","filing":"0000899243-17-011007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317011007/doc4.xml","form_type":"4"}},{"id":4345609,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-25T16:05:38.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":4000,"price":11.061,"value":44244.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.65 to $11.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":115825,"source":{"system":"sec-edgar","filing":"0000899243-17-010851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010851/doc4.xml","form_type":"4"}},{"id":4345608,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-25T16:05:38.000Z","date":"2017-04-21","kind":"sale","acquired":false,"shares":4000,"price":11.451,"value":45804.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 21, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.35 to $11.55. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":119825,"source":{"system":"sec-edgar","filing":"0000899243-17-010851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010851/doc4.xml","form_type":"4"}},{"id":4347729,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-21T16:05:26.000Z","date":"2017-04-20","kind":"sale","acquired":false,"shares":4000,"price":11.455,"value":45820.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 20, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.15 to $11.55. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":123825,"source":{"system":"sec-edgar","filing":"0000899243-17-010709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010709/doc4.xml","form_type":"4"}},{"id":4347728,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-21T16:05:26.000Z","date":"2017-04-19","kind":"sale","acquired":false,"shares":4000,"price":11.033,"value":44132.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.90 to $11.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":127825,"source":{"system":"sec-edgar","filing":"0000899243-17-010709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010709/doc4.xml","form_type":"4"}},{"id":4349788,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-19T16:09:00.000Z","date":"2017-04-18","kind":"sale","acquired":false,"shares":4000,"price":10.639,"value":42556.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 18, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.475 to $10.825. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":131825,"source":{"system":"sec-edgar","filing":"0000899243-17-010524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010524/doc4.xml","form_type":"4"}},{"id":4349787,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-19T16:09:00.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":4000,"price":10.769,"value":43076.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 17, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.55 to $11.15. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":135825,"source":{"system":"sec-edgar","filing":"0000899243-17-010524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010524/doc4.xml","form_type":"4"}},{"id":4349786,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-19T16:09:00.000Z","date":"2017-04-13","kind":"sale","acquired":false,"shares":4000,"price":10.431,"value":41724.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.30 to $10.65. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":139825,"source":{"system":"sec-edgar","filing":"0000899243-17-010524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010524/doc4.xml","form_type":"4"}},{"id":4349785,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":163897,"kind":"person","name":"Palti Yoram","position":1,"cik":"0001654403","reported_name":"Palti Yoram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2017-04-19T16:09:00.000Z","date":"2017-04-12","kind":"sale","acquired":false,"shares":4000,"price":10.716,"value":42864.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 12, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.40 to $11.05. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":143825,"source":{"system":"sec-edgar","filing":"0000899243-17-010524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654403/000089924317010524/doc4.xml","form_type":"4"}}]}